These neurologic changes have a detrimental impact on cognition and daily living and are often exacerbated among individuals at genetic risk for AD (e.g., positive for at least one APOE-ε4 allele) (Corder et al., 1993). The gene discussed is APOE; the disease is Alzheimer disease.